Evidence guide
How to evaluate a proposed cell product
A condition name alone cannot determine a cell type, dose or delivery route. Those choices depend on the exact product, indication, evidence, regulatory status and an individual clinical assessment.
Medical review statusPending clinical sign-offLast evidence update: 2026-08-05Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.
Ask for the exact product, not a broad label
- Product name, cell source, donor relationship and processing method.
- Proposed indication, route, dose and number of administrations.
- Current authorisation or trial identifier for that exact use.
- Manufacturing authorisation, release tests, traceability and adverse-event plan.
- Primary clinical evidence and realistic alternatives, reviewed by an independent physician.
This page does not select a treatment. Start with the condition evidence pages, verify registered studies on ClinicalTrials.gov, and use the clinic-verification checklist.